359 related articles for article (PubMed ID: 32446394)
1. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
3. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
4. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
5. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.
Yuan H; Zhao L; Yuan Y; Yun H; Zheng W; Geng Y; Yang G; Wang Y; Zhao M; Zhang X
Theranostics; 2021; 11(17):8362-8378. PubMed ID: 34373747
[No Abstract] [Full Text] [Related]
6. Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription.
Deng JJ; Kong KE; Gao WW; Tang HV; Chaudhary V; Cheng Y; Zhou J; Chan CP; Wong DK; Yuen MF; Jin DY
Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):491-501. PubMed ID: 28242208
[TBL] [Abstract][Full Text] [Related]
7. HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome.
Yang G; Feng J; Liu Y; Zhao M; Yuan Y; Yuan H; Yun H; Sun M; Bu Y; Liu L; Liu Z; Niu JQ; Yin M; Song X; Miao Z; Lin Z; Zhang X
Theranostics; 2019; 9(24):7345-7358. PubMed ID: 31695772
[No Abstract] [Full Text] [Related]
8. Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway.
Wen X; Li D; Chen P; Tan M; Zhang H; Liu Y; Ren J; Cheng S
Virus Res; 2024 Jan; 339():199273. PubMed ID: 38029800
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells.
Luo L; Chen S; Gong Q; Luo N; Lei Y; Guo J; He S
Int J Mol Med; 2013 Jan; 31(1):197-204. PubMed ID: 23128981
[TBL] [Abstract][Full Text] [Related]
10. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
11. IFN-α inhibits HBV transcription and replication by promoting HDAC3-mediated de-2-hydroxyisobutyrylation of histone H4K8 on HBV cccDNA minichromosome in liver.
Zhao LN; Yuan HF; Wang YF; Yun HL; Zheng W; Yuan Y; Geng Y; Zhao M; Feng LY; Zhang XD
Acta Pharmacol Sin; 2022 Jun; 43(6):1484-1494. PubMed ID: 34497374
[TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
13. Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells.
Peng B; Jing Z; Zhou Z; Sun Y; Guo G; Tan Z; Diao Y; Yao Q; Ping Y; Li X; Ren T; Li B; Li W
J Virol; 2023 Jan; 97(1):e0171722. PubMed ID: 36475867
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
Kim ES; Zhou J; Zhang H; Marchetti A; van de Klundert M; Cai D; Yu X; Mitra B; Liu Y; Wang M; Protzer U; Guo H
PLoS Pathog; 2022 Jun; 18(6):e1010576. PubMed ID: 35679251
[TBL] [Abstract][Full Text] [Related]
15. Methylation profile of hepatitis B virus is not influenced by interferon α in human liver cancer cells.
Moon IY; Kim JW
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396432
[TBL] [Abstract][Full Text] [Related]
16. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.
Lucifora J; Arzberger S; Durantel D; Belloni L; Strubin M; Levrero M; Zoulim F; Hantz O; Protzer U
J Hepatol; 2011 Nov; 55(5):996-1003. PubMed ID: 21376091
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
[TBL] [Abstract][Full Text] [Related]
19. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
20. Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx.
Cheng ST; Hu JL; Ren JH; Yu HB; Zhong S; Wai Wong VK; Kwan Law BY; Chen WX; Xu HM; Zhang ZZ; Cai XF; Hu Y; Zhang WL; Long QX; Ren F; Zhou HZ; Huang AL; Chen J
J Hepatol; 2021 Mar; 74(3):522-534. PubMed ID: 32987030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
